FAQ

Q. Isn’t there a risk that this will accelerate the adoption of drugs that aren’t ready and aren’t safe yet?

By Bryce / February 13, 2019 / 0 Comments

This isn’t a trade-off between speed and safety. This is about getting medicines designed specifically for patients who express biological characteristics (biomarkers) that increase the odds that a treatment will actually work for them. FDA is streamlining approvals for these treatments and personalized medicine can arguably have better safety and efficacy profiles than one-size fits […]

Q. Isn’t this just for the top 1% of patients with financial means?

By Bryce / February 13, 2019 / 0 Comments

No. Anybody with advanced cancer can demand and receive this. If your insurance doesn’t cover it, ask for financial assistance from the place doing the test.

Q. Regarding clinical trials, are there good trusted sources out there for me to find the right clinical trial “match” based on having genomic sequencing results?

By Bryce / February 13, 2019 / 0 Comments

There’s new innovation going on in this space. Most of the commercial diagnostic test companies listed earlier will offer clinical trial matching as part of their report back to patients and doctors. Other good sources include ClinicalTrials.gov, which is a database of privately and publicly funded clinical studies conducted around the world (though a little […]

Q. What kind of results should I expect from these tests to help guide my care?

By Bryce / February 13, 2019 / 0 Comments

Each individual cancer is unique and test results vary depending on the tumor type. When applicable, test results may help identify the following insights. 1. New insights into the preferred ‘on-label’ standard of care therapies. This means therapies approved to treat your specific tumor type and shown to be effective in targeting one or more […]

Q. Do all the test results lead to actionable treatment options?

By Bryce / February 13, 2019 / 0 Comments

Foundation Medicine has reported on that. Of the 79,000 cancer patients FMI tested in 2017, 38% percent were matched with an FDA approved therapy, 83% percent were matched with at least one relevant clinical trial, and all of them had at least one of those two outcomes.

Q. Am I contributing also to the greater good by doing this?

By Bryce / February 13, 2019 / 0 Comments

Absolutely! You are helping accelerate cancer research and drug development by doing this. Almost all of the companies that provide these tests partner with bio-pharma clients throughout each stage of drug research and development, from target discovery to commercial launch. We need to develop better drugs, faster. Broad testing of patients would make more data […]

Q. My doctor said there isn’t any new FDA approved drugs for me and is pushing back on ordering the test. What do I do?

By Bryce / February 13, 2019 / 0 Comments

Tell your doctor that you want new doors opened. You want new hope. Besides the standard of care, you want to consider targeted therapy, appropriate clinical trials that go after the same molecular targets driving your cancer, or off label treatments that may be effective for your specific tumor mutations. All of these options can […]

Q. What if my doctor thinks this is a waste of time?

By Bryce / February 13, 2019 / 0 Comments

Download the ‘battle card’ we’re offering, print it and bring it to your next doctor appointment. Buying and wearing the t-shirt will also help spark a conversation. Remind your doctor that cancer is a genetic disease and that the DNA of your cells have become mutated and you want to know what those mutations are. […]

Q. How does genomic testing differ from genetic testing?

By Bryce / February 13, 2019 / 0 Comments

Genetic testing detects hereditary (inherited from parents) alterations in DNA while genomic testing detects acquired (over the course of a lifetime) alterations in DNA. Acquired alterations are responsible for the majority of cancers and may impact tumor growth, spread, and response to therapy. Comprehensive genomic profiling (CGP) is far superior to single-gene testing that only […]

Q. Why is it important to get “sequenced”?

By Bryce / February 13, 2019 / 0 Comments

Because it helps get the right drug to the right patient at the right time. It’s how we really move to ‘value-based care’ or ‘outcome driven healthcare.’ It can help open new doors beyond the ‘standard of care’ which is more of a one-size-fits-all approach to cancer care that doesn’t take into consideration the uniqueness […]